22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026
Rhea-AI Summary
22nd Century Group (Nasdaq: XXII) will report fourth quarter and full year 2025 results on March 26, 2026, issuing a press release at 6:00 AM ET and hosting a live webcast at 8:00 AM ET.
Chairman and CEO Larry Firestone and CFO Dan Otto will review results, discuss recent progress and outline 2026 plans. The live and archived webcast will be available on the company's Events page at https://ir.xxiicentury.com/events.
Positive
- None.
Negative
- None.
News Market Reaction – XXII
In the Mar 23 session, XXII declined 1.68%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 23 | VLN sales update | Positive | +0.6% | Reported early VLN® sales traction and expanding retail distribution footprint. |
| Feb 20 | Preliminary earnings | Negative | -15.6% | Preliminary 2025 results showed revenue decline and net loss despite no long-term debt. |
| Jan 15 | Year-in-review letter | Positive | +0.8% | CEO letter highlighted restructuring exit, VLN® relaunch, and improved balance sheet. |
| Jan 12 | Conference participation | Neutral | -6.0% | Announcement of Needham conference presentation and investor meetings. |
| Jan 06 | MRTP renewal filing | Positive | -4.2% | Filed MRTP renewal for VLN®, the only FDA-authorized reduced-risk combustible cigarette. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news with clear fundamental implications often saw aligned price moves, while regulatory/strategic positives sometimes met with negative reactions.
Over the last few months, XXII has highlighted VLN® commercialization, regulatory positioning, and restructuring progress. A Jan 6 MRTP renewal filing and a Jan 15 year-in-review emphasized reduced-nicotine products and a strengthened balance sheet. Preliminary 2025 results on Feb 20 showed lower revenue but narrowed losses, followed by a Q4 VLN® sales update on Feb 23. Today’s earnings-date announcement fits into this ongoing communication of 2025 performance and 2026 plans.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MOCKSVILLE, N.C., March 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, will host a webcast on Thursday, March 26, 2026, at 8:00 AM ET to discuss its 2025 fourth quarter and full year results, which are to be reported in a press release at 6:00 AM ET the same day.
During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results, discuss progress made in the recent months and update plans for the 2026 year.
The live and archived webcast will be accessible on the Events web page in the Company's Investor Relations section of the website, at https://ir.xxiicentury.com/events. Please access the website at least 10 minutes prior to the start of the webcast to register and, if necessary, download and install any required software.
About 22nd Century Group, Inc.
22nd Century Group is pioneering the tobacco harm reduction movement by enabling smokers to take control of their nicotine consumption.
Our Technology is Tobacco
Our proprietary non-GMO reduced nicotine tobacco plants were developed using our patented technologies that regulate alkaloid biosynthesis activities resulting in a tobacco plant that contains
Our Products
We created our flagship product, the VLN® cigarette using our low nicotine tobacco, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption. VLN® cigarettes have
FDA Authorization and Scientific Foundation
VLN® low nicotine combustible cigarettes were authorized in December 2021, making them the first and still the only combustible cigarettes authorized by the U.S. Food and Drug Administration specifically to help reduce nicotine consumption.
Decades of independent clinical research and peer-reviewed studies—evaluated as part of the FDA’s Modified Risk Tobacco Product (MRTP) authorization process—demonstrated that reducing nicotine content can decrease nicotine intake, increase quit attempts, and reduce overall exposure to nicotine.
FDA-authorized VLN® claims include:
- “
95% less nicotine” - “Helps reduce your nicotine consumption”
- “Greatly reduces your nicotine consumption”
- “Helps you smoke less”
VLN® and Helps You Smoke Less® are registered trademarks of 22nd Century Limited LLC.
Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.
Learn more about VLN® at tryvln.com.
Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, and (iii) our financial and operating performance. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 20, 2025 and Quarterly Reports on Form 10-Q on May 13, 2025, August 14, 2025, and November 4, 2025. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.
Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
investorrelations@xxiicentury.com
214-597-8200
